We understand how devastating cognitive impairment can be. Neurological disorders are the leading cause of death and disability in the world today with about 1 in 7 people suffering from neurological disorders. These disorders severely disrupt lives and often lead to premature death. It is our responsibility to our contributors to conduct our research studies meticulously, thereby making the entire process and goals easily understood. We want you, the consumer, to know what our studies are about.
Upcoming Research Projects
swLORETA Indicators of Symptoms in ME/CFS and Long Covid
Evidence shows that a growing number of patients with COVID-19 infection will experience a post-viral syndrome known as Long COVID. Few systematic studies exist which investigate this population, and, relatively little is known about the neurocognitive underpinnings of symptoms severity and impact on daily functioning. This pilot study is designed for patients with a diagnosis of Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) and Long Covid-19. It will utilize qEEG recordings to perform 3-dimensional brain mapping and brain connectivity analyses in order to evaluate the nature and extent of neurological symptoms characterizing both patient groups. The primary aims of the study are 1) to assess the neuropsychological status of the participants, 2) linkage of symptoms and behavior to functional brain dysregulation using qEEG/swLORETA techniques. The results may provide valuable information for understanding the phenomenon of post-viral fatigue and cognitive/autonomic impairment related to each condition. There is no compensation, but participants get to view their EEG activity in real time and receive a brief summary of significant differences compared to age-adjusted normative database.
The slideshow below shows examples of significant brain network dysregulation in terms of brain mapping and functional connectivity.